0 NASDAQ Companies - February 28, 2024ADMA Biologics Announces CFO TransitionRAMSEY, N.J. and BOCA RATON, Fla., Feb. 28, 2024 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the […]Read More
0 NASDAQ Companies - February 28, 2024Monster Beverage Reports 2023 Fourth Quarter and Full-Year Financial Results— Record Fourth Quarter Net Sales Rise 14.4 Percent to $1.73 Billion —— Net Sales, Adjusted for Adverse Changes in […]Read More
0 NASDAQ Companies - February 28, 2024Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2023– Quarterly Revenue of $130.4 million, up 38% Year-Over-Year – – Gross Margin of 42.5% – – Net Income of $16.6 million – – Adjusted […]Read More
0 NASDAQ Companies - February 28, 2024RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality […]Read More
0 NASDAQ Companies - February 28, 2024Sana Biotechnology to Present at the Cowen 44th Annual Health Care ConferenceSEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for […]Read More
0 NASDAQ Companies - February 28, 2024Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care ConferenceREDWOOD CITY, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use […]Read More
0 NASDAQ Companies - February 28, 2024EverQuote to Participate in Upcoming Investor ConferencesCAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) — EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, today announced that […]Read More
0 NASDAQ Companies - February 28, 2024Inari Medical Reports Fourth Quarter 2023 Financial ResultsIRVINE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a […]Read More
0 NASDAQ Companies - February 28, 2024Inhibikase Therapeutics Announces Full Outcomes of its Pre-NDA Meeting with the FDA for IkT-001ProBOSTON and ATLANTA, Feb. 28, 2024 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical […]Read More
0 NASDAQ Companies - February 28, 2024Alkami Announces Fourth Quarter 2023 Financial ResultsPLANO, Texas, Feb. 28, 2024 (GLOBE NEWSWIRE) — Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami”), a leading cloud-based digital banking solutions […]Read More